scholarly journals Brca1 in immunoglobulin gene conversion and somatic hypermutation

DNA Repair ◽  
2008 ◽  
Vol 7 (2) ◽  
pp. 253-266 ◽  
Author(s):  
Simonne Longerich ◽  
Brian J. Orelli ◽  
Richard W. Martin ◽  
Douglas K. Bishop ◽  
Ursula Storb
2017 ◽  
Vol 47 (6) ◽  
pp. 993-1001 ◽  
Author(s):  
Paulina M Budzyńska ◽  
Minna K Kyläniemi ◽  
Teemu Kallonen ◽  
Anni I Soikkeli ◽  
Kalle-Pekka Nera ◽  
...  

Leukemia ◽  
2020 ◽  
Vol 34 (10) ◽  
pp. 2545-2551 ◽  
Author(s):  
Frédéric Davi ◽  
◽  
Anton W. Langerak ◽  
Anne Langlois de Septenville ◽  
P. Martijn Kolijn ◽  
...  

Abstract Twenty years after landmark publications, there is a consensus that the somatic hypermutation (SHM) status of the clonotypic immunoglobulin heavy variable (IGHV) gene is an important cornerstone for accurate risk stratification and therapeutic decision-making in patients with chronic lymphocytic leukemia (CLL). The IGHV SHM status has traditionally been determined by conventional Sanger sequencing. However, NGS has heralded a new era in medical diagnostics and immunogenetic analysis is following this trend. There is indeed a growing demand for shifting practice and using NGS for IGHV gene SHM assessment, although it is debatable whether it is always justifiable, at least taking into account financial considerations for laboratories with limited resources. Nevertheless, as this analysis impacts on treatment decisions, standardization of both technical aspects, and data interpretation becomes essential. Also, the need for establishing new recommendations and providing dedicated education and training on NGS-based immunogenetics is greater than ever before. Here we address potential and challenges of NGS-based immunogenetics in CLL. We are convinced that this perspective helps the hematological community to better understand the pros and cons of this new technological development for CLL patient management.


Cell ◽  
1991 ◽  
Vol 64 (1) ◽  
pp. 201-208 ◽  
Author(s):  
Louise M. Carlson ◽  
Marjorie A. Oettinger ◽  
David G. Schatz ◽  
Emma L. Masteller ◽  
Elizabeth A. Hurley ◽  
...  

PLoS ONE ◽  
2016 ◽  
Vol 11 (2) ◽  
pp. e0149146 ◽  
Author(s):  
Alan M. Williams ◽  
Yaakov Maman ◽  
Jukka Alinikula ◽  
David G. Schatz

2004 ◽  
Vol 72 (6) ◽  
pp. 3505-3514 ◽  
Author(s):  
Jianhui Zhou ◽  
Kathleen R. Lottenbach ◽  
Stephen J. Barenkamp ◽  
Donald C. Reason

ABSTRACT Combinatorial cloning and expression library analysis were used to determine the expressed human antibody repertoire specific for the capsular polysaccharide (PS) of Streptococcus pneumoniae serotype 6B. Sequence analysis of 55 6B-specific antibody Fab fragments isolated from six vaccinated donors reveal that different individuals used a variety of heavy and light chain germ line variable (V) region genes to form pneumococcal capsular PS (PPS) 6B-specific paratopes. Within each donor, however, the response was more restricted, with five of the six donors using at most one or two gene pairs to form combining sites. Analysis also indicated that although the response in each donor was oligoclonal in terms of variable gene usage, the combination of extensive somatic hypermutation, deletion of germ line-encoded residues, insertion of non-germ line-encoded residues, and intraclonal isotype switching generated a surprising degree of paratope diversity within the individuals analyzed. In contrast to previously studied PS-specific responses, we find that the PPS 6B repertoire makes use of a diverse collection of heavy-chain and light-chain V region gene products to form specific paratopes, with no apparent tendency for conservation of immunoglobulin gene usage between individuals.


2005 ◽  
Vol 98 (2) ◽  
pp. 259-264 ◽  
Author(s):  
Takeyuki Shimizu ◽  
Takachika Azuma ◽  
Mariko Ishiguro ◽  
Naoko Kanjo ◽  
Shuichi Yamada ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document